SCHEMBL5047684

SCHEMBL5047684

CCCCCCCCCCCc1noc(-c2ccc(C([NH])Cc3ccccc3OC)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
S1PR1 P21453 1/20 0.40
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SPHK1 Q9NYA1 1/20 0.37
APLNR P35414 1/20 0.37
TP53 P04637 1/20 0.37
CHRM2 P08172 3/20 0.36
CHRM4 P08173 3/20 0.36
CHRM5 P08912 3/20 0.36
CHRM1 P11229 3/20 0.36
CHRM3 P20309 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5044858 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL7064619 0.82 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL5048957 0.80 NPC1 (0.42) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL5048827 0.80 NPC1 (0.42) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL6022341 0.80 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL5044699 0.80 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL5045233 0.79 KDM4E (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL1853005 0.79 SPHK1 (0.47) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL1853076 0.79 SPHK1 (0.47) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1
SCHEMBL5047614 0.79 KDM4E (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732534-B1 USE OF METHYLENE AMIDE DERIVATIVES IN CARDIOVASCULAR DISORDERS SERONO LAB (CH) 2008-07-23 EP claimed